Skip to main content
B

BIDE PHARMATECH CO., LTD. — Investor Relations & Filings

Ticker · 688073 Shanghai Stock Exchange Manufacturing
Filings indexed 480 across all filing types
Latest filing 2026-01-05 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688073

About BIDE PHARMATECH CO., LTD.

Bide Pharmatech Co., Ltd. specializes in the research, development, and supply of high-quality chemical building blocks and specialty reagents for the global pharmaceutical and biotechnology sectors. The company offers an extensive portfolio of small molecule organic compounds, including functionalized heterocycles, catalysts, ligands, and advanced intermediates essential for drug discovery and chemical research. Bide Pharmatech provides comprehensive services ranging from catalog product distribution to custom synthesis and contract research, supporting clients through various stages of the drug development lifecycle. With a focus on technical innovation and rigorous quality control, the firm facilitates efficient lead optimization and process development for academic institutions and commercial laboratories worldwide.

Recent filings

Filing Released Lang Actions
2025年半年度报告(修订版)
Regulatory Filings
2026-01-05 Chinese
关于2025年半年度报告的更正公告
Regulatory Filings
2026-01-05 Chinese
国泰海通证券股份有限公司关于上海毕得医药科技股份有限公司补充确认2025年度日常关联交易的核查意见
Regulatory Filings
2026-01-05 Chinese
股东减持计划时间届满暨减持股份结果公告
Regulatory Filings
2025-12-29 Chinese
股东减持股份计划公告
Regulatory Filings
2025-12-29 Chinese
关于股东权益变动触及5%整数倍的提示性公告
Regulatory Filings
2025-12-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.